Teva Pharmaceutical Industries

TEVANYSE Israel Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$45.458 B

$39.01 -1.29%

Close of 23 Sept 2026

Revenue

$17.3B

#260 by revenue

Earnings

$1.41B

#299 by earnings

Shares outstanding

1,165,296,084

Latest filing cover page

P/E ratio

32.2

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 500 →

#14Regeneron PharmaceuticalsREGN$82.6B
#15Takeda PharmaceuticalTAK$59.4B
#16Teva Pharmaceutical IndustriesTEVA$45.5B
#17BeOne MedicinesONC$41.5B
#18Royalty PharmaRPRX$33.1B

What if Teva Pharmaceutical Industries were worth as much as…

Open the what-if tool →

Gold $29.8T

$25,613.17

Per share 657× higher

Bitcoin $1.69T

$1,453.81

Per share 37.3× higher

Nvidia $5.43T

$4,663.87

Per share 120× higher

Or at a round number

$100.0B $200.0B $500.0B $1.00T

Where these numbers come from

Share counts and financials for Teva Pharmaceutical Industries are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 24 Sept 2026. Read the methodology.